Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement.
In: Leukemia & lymphoma, Jg. 65 (2024-05-01), Heft 5, S. 669-673
academicJournal
Zugriff:
Titel: |
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement.
|
---|---|
Autor/in / Beteiligte Person: | Lionel, AC ; Gurumurthi, A ; Fetooh, A ; Eldaya, R ; Ahmed, S ; Iyer, SP ; Nastoupil, LJ ; Westin, J ; Nair, R ; Fayad, L ; Malpica, L ; Tummala, S ; Flowers, C ; Neelapu, SS ; Wang, ML ; Jain, P |
Zeitschrift: | Leukemia & lymphoma, Jg. 65 (2024-05-01), Heft 5, S. 669-673 |
Veröffentlichung: | [Philadelphia, PA] : Taylor & Francis ; <i>Original Publication</i>: Chur ; New York : London, UK : Harwood Academic Publishers ; Distributed by STBS, 1989-, 2024 |
Medientyp: | academicJournal |
ISSN: | 1029-2403 (electronic) |
DOI: | 10.1080/10428194.2024.2304622 |
Schlagwort: |
|
Sonstiges: |
|